关注
Godfrey Barabona
Godfrey Barabona
在 kumamoto-u.ac.jp 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring
G Barabona, M Mahiti, S Masoud, P Mbelele, AS Mgunya, L Minja, ...
Journal of Antimicrobial Chemotherapy 74 (10), 3016-3020, 2019
122019
Circulating HIV-1 integrase genotypes in Tanzania: implication on the introduction of integrase inhibitors-based antiretroviral therapy regimen
S Masoud, D Kamori, G Barabona, M Mahiti, B Sunguya, E Lyamuya, ...
AIDS research and human retroviruses 36 (6), 539-543, 2020
62020
Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike
TS Tan, M Toyoda, H Ode, G Barabona, H Hamana, M Kitamatsu, H Kishi, ...
Journal of virology 96 (20), e01162-22, 2022
32022
Phenotypic and genotypic Co-receptor tropism testing in hiv-1 epidemic region of Tanzania where multiple non-b subtypes Co-circulate
GP Judicate, G Barabona, D Kamori, M Mahiti, TS Tan, S Ozono, ...
Frontiers in Microbiology, 1788, 2021
32021
Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance …
D Kamori, G Barabona, J Rugemalila, W Maokola, SS Masoud, ...
Journal of Antimicrobial Chemotherapy 78 (3), 779-787, 2023
22023
Acquired HIV drug resistance among children and adults receiving antiretroviral therapy in Tanzania: a national representative survey protocol
J Rugemalila, D Kamori, W Maokola, M Mizinduko, G Barabona, ...
BMJ open 11 (12), e054021, 2021
22021
Advanced baseline immunosuppression is associated with elevated levels of plasma markers of fungal translocation and inflammation in long-term treated HIV-infected Tanzanians
G Barabona, M Mahiti, M Toyoda, D Kamori, S Masoud, GP Judicate, ...
AIDS Research and Therapy 18 (1), 1-10, 2021
22021
Seroprevalence of human herpesvirus infections in newly diagnosed HIV-infected key populations in Dar es Salaam, Tanzania
D Kamori, M Mizinduko, G Barabona, M Mahiti, U Kibwana, M Majigo, ...
International Journal of Microbiology 2021, 2021
22021
HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania
J Rugemalila, D Kamori, P Kunambi, M Mizinduko, A Sabasaba, ...
Plos one 18 (2), e0281528, 2023
12023
Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV-infected adults initiating antiretroviral therapy in Urban Tanzania
TM Mwakyandile, GA Shayo, PG Sasi, FM Mugusi, G Barabona, T Ueno, ...
BMC Cardiovascular Disorders 23 (1), 1-9, 2023
2023
Evaluation of Neutralizing Activity against Omicron Subvariants in BA. 5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated …
M Toyoda, TS Tan, C Motozono, G Barabona, A Yonekawa, N Shimono, ...
Microbiology Spectrum, e00660-23, 2023
2023
Erratum for Tan et al.,“Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike”
TS Tan, M Toyoda, H Ode, G Barabona, H Hamana, M Kitamatsu, H Kishi, ...
Journal of Virology 96 (23), e01737-22, 2022
2022
Protocol: Acquired HIV drug resistance among children and adults receiving antiretroviral therapy in Tanzania: a national representative survey protocol
J Rugemalila, D Kamori, W Maokola, M Mizinduko, G Barabona, ...
BMJ Open 11 (12), 2021
2021
Circulating pre-treatment and acquired HIV drug resistance Mutations in Dar es Salaam, Tanzania
G BARABONA
2020
学 位 論 文
B Godfrey
School of Medical Sciences, Kumamoto University, 2020
2020
Abstracts of the HIV Research for Prevention Meeting, HIVR4P, 21-25 October, 2018, Madrid
Z Shen, M Rodriguez-Garcia, M Patel, J Bodwell, C Wira, O Chuchuen, ...
AIDS Research and Human Retroviruses 34 (S1), 1-407, 2018
2018
Circulating HIV-1 Drug Resistance Mutations in Dar Es Salaam, Tanzania: Implication for Pre-exposure Prophylaxis
G Barabona, MD Mahiti, S Masoud, P Mbelele, AS Mgunya, L Minja, ...
AIDS RESEARCH AND HUMAN RETROVIRUSES 34, 132-132, 2018
2018
Dolutegravir resistance in Sub-Saharan Africa: Should resource-limited settings be concerned for future treatment?
D Kamori, G Barabona
Frontiers in Virology 3, 1253661, 0
系统目前无法执行此操作,请稍后再试。
文章 1–18